Complexo Hospitalario Universitario de Santiago
Centro de atención
Hospital San Pedro de Alcántara
Cáceres, EspañaPublicacións en colaboración con investigadores/as de Hospital San Pedro de Alcántara (63)
2024
-
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience
Annals of Hematology, Vol. 103, Núm. 2, pp. 451-461
-
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Haematologica, Vol. 109, Núm. 1, pp. 115-128
2023
-
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
Journal of Clinical Virology, Vol. 167
-
Beyond hyperglycemia: glycaemic variability as a prognostic factor after acute ischemic stroke
Neurologia, Vol. 38, Núm. 3, pp. 150-158
-
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901
-
Coeliac Disease Case–Control Study: Has the Time Come to Explore beyond Patients at Risk?
Nutrients, Vol. 15, Núm. 5
-
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols
HemaSphere
-
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247
-
Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)
Cardiovascular Diagnosis and Therapy, Vol. 13, Núm. 5
2022
-
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry
Cancers, Vol. 14, Núm. 9
-
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia
Cancers, Vol. 14, Núm. 11
-
Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry
Catheterization and Cardiovascular Interventions, Vol. 99, Núm. 4, pp. 961-967
-
Correlation of Anti-Tissue Transglutaminase Antibodies With the Mucosal Changes and IgA Status of Children With Celiac Disease
Journal of pediatric gastroenterology and nutrition, Vol. 75, Núm. 6, pp. 743-748
-
Experience with the potassium binder patiromer in hyperkalaemia management in heart failure patients in real life
ESC Heart Failure, Vol. 9, Núm. 5, pp. 3071-3078
-
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study
Future oncology (London, England), Vol. 18, Núm. 35, pp. 3913-3927
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019
Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia
Cancer, Vol. 127, Núm. 12, pp. 2003-2014
-
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
Blood, Vol. 137, Núm. 14, pp. 1879-1894